Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2005-03-29
2005-03-29
Devi, S. (Department: 1645)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023100, C536S023400, C435S320100, C435S252300, C435S069300, C435S071100, C435S071200, C424S263100, C424S234100, C424S184100
Reexamination Certificate
active
06872814
ABSTRACT:
In summary of this disclosure, the present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specificallyC. pneumoniae, employing a vector, containing a nucleotide sequence encoding an 98 kDa putative outer membrane protein of a strain ofChlamydia pneumoniaeand a promoter to effect expression of the 98 kDa putative outer membrane protein gene in the host. Modifications are possible within the scope of this invention.
REFERENCES:
patent: 6403101 (2002-06-01), Murdin et al.
patent: WO 9858953 (1998-12-01), None
patent: WO 9927105 (1999-06-01), None
Houghten et al. Vaccines86, Cold Spring Harbor Laboratory. p. 21-25, 1986.*
Longbottom et al. Infect. Immun. 1317-1324, Apr., 1998.*
Bowie et al. Science 247: 11306-1310, 1990.*
Burgess et al. J. Cell Biol. 111:2129-2138, 1990.*
Lazar et al. Mol. Cellular Biol. 8: 1247-1252, 1988.*
Kalman, et al., Nature Genetics, 21, 385-389 (1999).
Magee, et al., Infection and Immunity, 63:2, 516-521 (1995).
Landers, et al., Infection and Immunity, 59:10, 3774-3777 (1991).
Jackson, et al., Abstracts of the 36th ICAAC, 272 (1996).
Magee, et al., Regional Immunology, 5, 305-311 (1993).
Igletseme, et al., Regional Immunology, 5, 317-324 (1993).
Jones, et al., Vaccine, 13:8, 715-723 (1995).
Pal, et al., Infection and Immunity, 64:12, 5341-5348 (1996).
Hahn, et al., The Journal of the American Medical Association, 266:2, 225-230 (1991).
Allegra, et al., European Respiratory Journal, 7:2, 2165-2168 (1994).
Björnsson, et al., Scandinavian Journal of Infectious Diseases, 28:1, 63-69 (1996).
Hahn, The Journal of Family Practice, 41:4, 345-351 (1995).
Hahn, et al., Epidemiology Infection, 117:3, 513-517 (1996).
Hahn, et al., Annals of Allergy, Asthma, and Immunology, 80:1, 45-49 (1998).
Fong, et al., Journal of Clinical Microbiology, 35:1, 48-52 (1997).
Ramirez, et al., Annals of Internal Medicine, 125:12, 979-982 (1996).
Chiu, et al., Circulation, 96:7, 2144-2148 (1997).
Campbell, et al., The Journal of Infectious Diseases, 172:2, 585-588 (1995).
Kuo, et al., Arteriosclerosis and Thrombosis, 13:10, 1501-1504 (1993).
Kuo, et al., The Journal of Infectious Disease, 167:4, 841-849 (1993).
Melnick, et al., The American Journal of Medicine, 95, 499-504 (1993).
Saikku, et al., Annals of Internal Medicine, 116:4, 273-278 (1992).
Grayston, et al., The Journal of Infectious Diseases, 168:5, 1231-1235 (1993).
Campos, et al., Investigative Opththalmology & Visual Science, 36:8, 1477-1491 (1995).
Grayston, et al., The Journal of Infectious Diseases, 161:4, 618-625 (1990).
Marrie, Clinical Infectious Dieases, 18:4, 501-515 (1994).
Wang et al., Chlamydial Infections, 329-333 (1986).
Saikku, et al., The Lancet, 2:8618, 983-985 (1998).
Thom, et al., The Journal of the American Medical Association, 268:1, 68-72 (1992).
Linnanmäki, et al., Circulation, 87:4, 1130-1134 (1993).
Bachmaier, et al., Science, 283, 1335-1339 (1999).
Iijima, et al., Journal of Clinical Microbiology, 32:3, 583-588 (1994).
Campbell, et al., Journal of Clinical Microbiology, 28:6, 1261-1264 (1990).
Melgosa, et al., FEMS Microbiology Letters, 112:2, 199-204 (1993).
Watson, et al., Microbiology, 141, 2489-2497 (1995).
Watson, et al., Nucleic Acids Research, 18:7, 5299 (1990).
Melgosa, et al., Infection and Immunity, 62:3, 880-886 (1994).
Takase, et al., Journal of Bacteriology, 169:12, 5692-5699 (1987).
Cagnon, et al., Protein Engineering, 4:7, 843-847 (1991).
Casey ,et al., Nucleic Acids Research, 4:5, 1539-1553 (1977).
Kunkel, et al., Proc. Natl. Acad. Sci. USA, 82, 488-492 (1985).
Langeveld, et al., Vaccine, 12:15, 1994.
Snijders, et al.,The Journal of General Virology, 72:3, 557-565 (1991).
Dio, et al., Virology, 179:1, 474-477 (1990).
Hughes, et al., Infection and Immunity, 60:9, 3497-3503 (1992).
Wiedmann-Al-Ahmad, et al., Clinical and Diagnostics Labratory Immunology, 4:6, 700-704 (1997).
McCafferty, et al., Infection and Immunity, 63:6, 2387-2389 (1995).
Campbell, et al., Infection and Immunity, 58:1, 93-97 (1990).
Cotter, et al., Infection and Immunity, 63:12, 4704-4714 (1995).
Chlamydia Genome Project, http://chlamydia-www.berkeley.edu:4231, updated Sep. 23, 1999.
Shor, et al., S AFR Med Journal, 82, 158-161 (1992).
Dunn Pamela L.
Murdin Andrew D.
Oomen Raymond P.
Aventis Pasteur Limited
Devi S.
Elrifi Ivor R.
Mintz Levin Cohn Ferris Glovsky & Popeo P.C.
Triano, III Nicholas P.
LandOfFree
Chlamydia antigens and corresponding DNA fragments and uses... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chlamydia antigens and corresponding DNA fragments and uses..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chlamydia antigens and corresponding DNA fragments and uses... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3422152